Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II Study of NBI-56418 in Subjects with Endometriosis
2007-006474-28Phase 2Completed
- Sponsor
- Neurocrine Biosciences
- Start
- Jan 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of elagolix in endometriosis (5 arms), sponsored by Neurocrine Biosciences. Primary endpoint: Safety endpoints. Started Jan 2008; status: completed.
02
Drugs
elagolix
03
Conditions
endometriosis
Beyond the preview
Go deeper on 2007-006474-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-006474-28.